Incubate CoalitionApr 5, 2022To Spend Less On Healthcare, Invest In More MedicinesRead John Stanford and JF Formela's op-ed on how we can lower health costs by spending more on drugs. By JF Formela and John Stanford The...
Incubate CoalitionFeb 2, 2022Moonshot StatementRead Incubate Executive Director John Stanford's statement on President BIden's Moonshot initiative. Incubate Executive Director John...
Incubate CoalitionNov 11, 2021The Impact Of Price Controls On Investment Into Small Biotech InnovationThis report attempts to understand the implications of price controls on the early-stage life science industry. In the U.S., policymakers...
Incubate CoalitionNov 4, 2021Leading Venture Capital Group Concerned With Prescription Drug Deal"As investors in biotechnology and pharmaceuticals, we're highly concerned about the potential consequences of the new drug-pricing...
Incubate CoalitionOct 20, 2021Cost Of Care: Rare Diseases Expose Need To Revamp US Drug Pricing PolicyDeveloping more effective treatments for patients with no other options while also keeping costs down will require a balancing act with...
Incubate CoalitionSep 10, 2021SIGNAL WATCHING: How Life Science Venture Capital Perceives Medicare Part D ReformsSIGNAL WATCHING: How Life Science Venture Capital Perceives Medicare Part D Reforms The 117th Congress is discussing a wide variety of...